For the geography segment; regional supply, demand, major players, and price is presented from 2019 to 2029.
This report covers the following regions:
- North America
- South America
- Asia & Pacific
- Europe
- MEA
For the competitor segment, the report includes global key players of Gene Editing as well as some smaller players.
The information for each competitor includes:
- Company Profile
- Business Information
- SWOT Analysis
- Revenue, Gross Margin and Market Share
Applications Segment:
- Drug Discovery
- Therapeutics
- Diagnostics
- Others
Companies Covered:
- CRISPR Therapeutics AG
- Intellia Therapeutics Inc.
- bluebird bio Inc.
- Ensoma Inc.
- Editas Medicine Inc.
- Beam Therapeutics Inc.
- Tessera Therapeutics Inc.
- Prime Medicine Inc
Historical Data: from 2019 to 2023
Forecast Data: from 2024 to 2029
This product will be delivered within 1-3 business days.
Table of Contents
Companies Mentioned
- CRISPR Therapeutics AG
- Intellia Therapeutics Inc.
- bluebird bio Inc.
- Ensoma Inc.
- Editas Medicine Inc.
- Beam Therapeutics Inc.
- Tessera Therapeutics Inc.
- Prime Medicine Inc
- Generation Bio